Gastrointestinal dysfunction affects a significant proportion of patients following major abdominal surgery, with up to 30% experiencing symptoms such as nausea, vomiting, obstipation, and abdominal pain. These symptoms, commonly referred to as postoperative ileus, contribute to delayed recovery, increased hospital stays, and elevated healthcare costs. Despite the prevalence of these issues, there has been no validated Patient-Reported Outcome Measure (PROM) specifically designed to assess gastrointestinal recovery in this context.
Existing tools for gastrointestinal-related quality of life are typically designed for chronic conditions and outpatient settings, failing to capture the acute postoperative experience. Clinical assessments often rely on binary indicators such as the passage of flatus, which do not reflect the multidimensional nature of recovery.
The PRO-diGI was developed to address this gap, offering a condition-specific PROM for gastrointestinal recovery after surgery. The development followed a rigorous four-stage process:
1. Item Generation – Semi-structured interviews with 29 patients across five UK hospitals identified 26 subthemes and informed a draft 44-item questionnaire.
2. Face Validity Assessment – Feedback from 18 patients and 15 clinical experts confirmed the tool’s acceptability and relevance.
3. Domain Development and Item Reduction – Principal component analysis (PCA) refined the questionnaire to 15 items across four domains.
4. Reliability and Responsiveness Testing – Test–retest reliability showed intraclass correlation coefficients ≥0.7 across all domains.
The development was guided by the COSMIN taxonomy and GRIPP-2 SF framework, with extensive patient and public involvement (PPI) throughout. Collaborators included health psychologists, colorectal nurses, surgeons, and lay representatives from institutions such as the University of Birmingham, University of Sheffield, Leeds Teaching Hospitals, and Leeds Beckett University.
The PRO-diGI is copyright 2024 by Sheffield Teaching Hospitals and licensing is managed by InSpired Health Outcomes Ltd, Oxford, UK.